Exalenz sets up H. Pylori test lab in US

• Exalenz Bioscience Ltd. (TASE:EXEN) has signed an agreement with New Hampshire-based Metabolic Solutions Inc., which will set up and operate an independent test laboratory to analyze diagnostic test results of the Helicobacter pylori (H. pylori) bacteria, a common cause of peptic ulcers. The center is due to begin operations in the first quarter of 2010.
• The test center will use Exalenz's BreathID diagnostic kits as well as IRMS devices for analyzing breath test results carried out by physicians across the US.